The abstract is read at the publisher; the summary is JClub's.
DGIdb’s 2026 release expands normalized drug–gene interaction and gene annotation data by adding three new interaction sources and improved programmatic tooling.
- Why it matters: Drug–gene interaction knowledge is scattered across therapeutic and biomedical resources, making it hard to access consistently for computational workflows and reproducible analyses.
- What they did: The team updated existing sources and incorporated Molecular Oncology Almanac, PRISM Repurposing Dataset, and Broad Institute Drug Repurposing Hub, alongside dgiPy/dgiR API clients and versioned Docker images.
- The result: The release provides FAIR, transparent, and reproducible access via a public repository with current and historical DGIdb data releases in TSV and SQL formats, plus ongoing web interface improvements.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.